CUBE vs TNXP · P/E 25, rev $1.07B vs rev $10.1M
CubeSmart (CUBE) versus Tonix Pharmaceuticals Holding Corp (TNXP) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Tonix Pharmaceuticals Holding Corp (TNXP) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported TNXP revenue for 2024-12-31 was $10.1M. Net income was -$130.0M. Revenue was up 29.9% from 2023-12-31 to 2024-12-31. TNXP currently screens at market cap $194.5M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. TNXP currently screens at market cap $194.5M.
Not investment advice. Open the CUBE and TNXP stock pages for the full models.
Not investment advice.